|本期目录/Table of Contents|

[1]赖福生,卢少军,王一芳,等.脐带血有核细胞移植治疗肌萎缩侧索硬化的临床研究[J].医学研究与战创伤救治(原医学研究生学报),2010,12(06):515-518.
　LAI Fu-sheng,LU Shao-jun,WANG Yi-fang,et al.Clinical study of treating amyotrophic lateral sclerosis with transplantation of umbilical cord blood nuclear cells[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2010,12(06):515-518.
点击复制

脐带血有核细胞移植治疗肌萎缩侧索硬化的临床研究()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第12卷
期数:
2010年06期
页码:
515-518
栏目:
出版日期:
2010-11-20

文章信息/Info

Title:
Clinical study of treating amyotrophic lateral sclerosis with transplantation of umbilical cord blood nuclear cells
文章编号:
1672-271X(2010)06-0515-04
作者:
赖福生; 卢少军; 王一芳; 焦冬生; 李惠俊; 江一帆; 钱时德
210002 江苏南京,解放军454医院神经科
Author(s):
LAI Fu-sheng;  LU Shao-jun;  WANG Yi-fang; JIAO Dong-sheng; LI Hui-jun; JIANG Yi-fan; QIAN Shi-de.
Department of Neurology，454 Hospital of PLA, Nanjing，Jiangsu 210002, China
关键词:
肌萎缩侧索硬化; 运动神经元病;  脐带血; 有核细胞;  移植
Keywords:
amyotrophic lateral sclerosis;  motor neuron disease;  umbilical cord blood;  nuclear cells;  transplantation
分类号:
R591.44
DOI:
-
文献标志码:
A
摘要:
目的观察脐带血有核细胞治疗肌萎缩侧索硬化(ALS)的疗效并探讨机制。方法采集新生儿脐带血，获取含干细胞的有核细胞混悬液，每份平均含有核细胞4.29×108个，通过腰椎穿刺，将其移植入蛛网膜下腔。结果移植后第5天患者单手握力较移植前平均增加1.68 kg;移植后第1个月94.46%患者病情好转; 第2个月5.12%持续好转，73.04%保持稳定;第3个月36.06%保持稳定;第4个月18.85%保持稳定；第5个月10.61%保持稳定。结论脐带血有核细胞蛛网膜下腔移植在一定时间内可有效缓解ALS的临床症状。
Abstract:
ObjectiveTo investigate the curative effect of umbilical cord blood nuclear cells transplantation on treating ALS and the mechanism of this therapy. MethodsUmbilical cord blood was collected, and the nuclear cell suspensions containing stem cells were made and injected into subarachnoid space of the patients. Each suspension contained 4.29×108 nuclear cells averagely. The movement functions of the cases were evaluated. Results5 days after transplantation, the single hand holding strength of patients averagely increased 1.68 kg compared with before treatment. 94.46% patients improved in the first month. 5.12% patients continued to improve and 73.04% patients maintain in stable condition in the second month. 36.06% patients maintained in stable condition in the third month.18.85% patients maintained in stable condition in the forth month.10.61% patients maintained in stable condition in the fifth month. ConclusionUmbilical cord blood nuclear cells transplantation may improve patients movement function in a certain time.

参考文献/References:

[1]Mitchell JD, Borasio GD. Amyotrophic lateral sclerosis[J].Lancet,2007,369(9578):2031-2041.
[2]Bensimon G, Lacomblez L, Meininger V. The ALS/Riluzole study group. A controlled trial of riluzole in amyotrophic lateral sclerosis [J]. N Engl J Med, 1994,330(9):585-591.
[3]赖福生，王一芳，李翠萍，等.自体骨髓有核细胞蛛网膜下腔移植治疗运动神经元病的临床研究[J].临床神经病学杂志，2005，18(1):10-12.
[4]Brooks BR, Miller RG, Swash M, et al. EI Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis [J]. Amyotroph Lateral Scier Other Motor Neuron Disord, 2000，1(5):293-299.
[5]李焰生，黄坚，庄建华.运动神经元疾病[M].上海:第二军医大学出版社，2002:207.
[6]Kim SU, de Vellis J. Stem cell-based cell therapy in neurological disease: a review [J]. J Neurosci Res， 2009, 87(10):2183-2200.
[7]Hwang DH, Lee HJ, Park IH, et al. Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice[J].Gene Ther, 2009 16(10):1234-44.
[8]黄红云，陈琳，王洪美，等.嗅鞘细胞移植治疗肌萎缩侧索硬化症:88例临床报告[J].中国临床康复，2006，10(1):39-41.
[9]曹红宾，李敏，王海燕，等.肌萎缩侧索硬化患者神经干细胞移植后中枢内的体液免疫反应[J].中国组织工程与临床康复，2008，12(38):7439-7442.
[10]Martinez HR, Gonzalez-Garza MT, Moreno-Cuevas, et al. Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients[J]. Cytotherapy, 2009, 11(1):26-34.
[11]Deda H, Inci MC, Kurekci AE, et al. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up[J].Cytotherapy,2009,11(1):18-25.
[12]Janson CG, Ramesh TM, During MJ, et al. Human intrathecal transplantation of peripheral blood stem cells in amyotrophic lateral sclerosis[J]. J Hematother Stem Cell Res, 2001, 10(6):913-915.
[13]Zurn AD, Henry H, Schluep M, et al. Evaluation of an intrathecal immune response in amyotrophic lateral sclerosis patients implanted with encapsulated genetically engineered xenogeneic cells[J]. Cell Transplant, 2000,9(4):471-484.
[14]Mazzini L, Ferrero I, Luparello V,et al. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial[J]. Exp Neurol， 2010,223(1):229-237.
[15]Silani V, Calzarossa C, Cova L, et al. Stem cells in amyotrophic lateral sclerosis: motor neuron protection or replacement[J]? CNS Neurol Disord Drug Targets， 2010, 9(3):314-324.
[16]Lunn JS, Hefferan MP, Marsala M, et al. Stem cells: comprehensive treatments for amyotrophic lateral sclerosis in conjunction with growth factor delivery[J].Grouth Factors, 2009,27(3):133-140.
[17]Graber JJ, Dhib-Jalbut S. Protective autoimmunity in the nervous system [J]. Pharmacol Ther, 2009, 121(2):147-159.
[18]Vijayalakshmi K, Alladi PA, Sathyaprabha TN, et al. Cerebrospinal fluid from sporadic amyotrophic lateral sclerosis patients induces degeneration of a cultured motor neuron cell line[J]. Brain Res, 2009, 1263(1):122-133.

相似文献/References:

[1]赵 伟,胡新国,王润兰.肌萎缩侧索硬化患者低密度脂蛋白的氧化敏感性[J].医学研究与战创伤救治(原医学研究生学报),2012,14(06):523.
　ZHAO Wei,HU Xin-guo,WANG Run-lan.Oxidized sensibility of low-density lipoproteins in patients with amyotrophic lateral sclerosis[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2012,14(06):523.

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2010-11-20